Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why CytRx Corporation Is Still A Big Biotech 'If' Play
Seeking Alpha
Wednesday, December 14, 2011 - 11:22am
tags:
CytRx
Charles River Labs predicts 2012 earnings growth, more stability in new year
Yahoo/AP
Wednesday, December 14, 2011 - 11:20am
tags:
Charles River Laboratories
Threshold Pharma announces clinical trial results of Phase 1 TH-302 study
Yahoo/Fly on the Wall
Wednesday, December 14, 2011 - 11:18am
tags:
Threshold Pharmaceuticals, leukemia, TH-302
Eli Lilly ends agreement with TransPharma
Globes, Israel
Wednesday, December 14, 2011 - 11:16am
tags:
TransPharma, Eli Lilly, diabetes, ViaDor-PTH1-34
Novo Nordisk (NVO) Owns 55% Of All Insulin Sales With A Patent Stretching To 2022; This Makes Them A Top Pick In Healthcare For The Chairman of Dividend Growth Advisors
Yahoo/Wall St Transcript
Wednesday, December 14, 2011 - 11:02am
tags:
diabetes, insulin, Novo Nordisk
Why Pharmacyclics is seeing put selling
Yahoo/optionMONSTER
Wednesday, December 14, 2011 - 11:01am
tags:
Pharmacyclics
NovaBay's Game-Changing Technology May Be Attracting Attention
Seeking Alpha
Wednesday, December 14, 2011 - 10:58am
tags:
NovaBay Pharmaceuticals, Aganocide, NVC-422, anti-infectives
KV Pharma May Not Be A Going Concern Very Long
Pharmalot
Wednesday, December 14, 2011 - 10:57am
tags:
KV Pharmaceutical, TheRx
Sanofi Accused Of Anticompetitive Vaccine Pricing
Pharmalot
Wednesday, December 14, 2011 - 10:56am
tags:
Sanofi, vaccines, drug pricing, Novartis, Menveo, Menactra
FDA Won’t Be Held in Contempt Over Plan B Order, Judge Rules
Bloomberg
Wednesday, December 14, 2011 - 10:55am
tags:
FDA, Teva Pharmaceuticals, Plan B contraceptive, morning-after pill
Ampio Pharmaceuticals: It's The Pipeline That Talks
Seeking Alpha
Wednesday, December 14, 2011 - 10:15am
tags:
Ampio, Ampion, Zertane, Optina
Merck CEO defends hefty research spending
Yahoo/Reuters
Wednesday, December 14, 2011 - 9:47am
tags:
Merck, Pharma CEOs, R&D, Kenneth Frazier
Pfizer Rises after Shift in Company’s Board
Barron's
Wednesday, December 14, 2011 - 9:44am
tags:
Pfizer, Ian Read
5 Healthcare Merger Candidates To Consider
Seeking Alpha
Wednesday, December 14, 2011 - 9:43am
tags:
Pfizer, Watson, Becton Dickinson, Obagi Medical Products, PhotoMedex
Pfizer elects CEO Read as company chair
Fierce Pharma
Tuesday, December 13, 2011 - 11:58am
tags:
Pfizer, Ian Read, Pharma CEOs
Endocyte plunges on drug study results
Marketwatch
Tuesday, December 13, 2011 - 11:56am
tags:
Endocyte, EC145, ovarian cancer
Seattle Genetics’ Adcetris Is Well Tolerated in Drug Combination
Bloomberg
Tuesday, December 13, 2011 - 11:48am
tags:
Adcetris, Seattle Genetics, Hodgkin's lymphoma
Avanir's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Seeking Alpha
Tuesday, December 13, 2011 - 11:47am
tags:
Avanir, earnings
An Overview Of Antares' And Teva's Collaboration On Self-Injection Drugs
Seeking Alpha
Tuesday, December 13, 2011 - 11:46am
tags:
Teva Pharmaceuticals, Antares, self-injectibles
Anacor Pharma's skin drugs show promise in mid-stage trial
Reuters
Tuesday, December 13, 2011 - 11:45am
tags:
Anacor, eczema, AN2728

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.